Bone Marrow Failure Syndrome clinical trials
9 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
- Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Allo HSCT Using RIC and PTCy for Hematological Diseases
- Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
- Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
- A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
- Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Bone Marrow Failure Syndrome” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.